TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

SUPRAX

CEFIXIME
Infectious Disease Approved 1989-04-28
9
Indications
--
Phase 3 Trials
36
Years on Market

Details

Status
Prescription
First Approved
1989-04-28
Routes
ORAL
Dosage Forms
CAPSULE, FOR SUSPENSION, TABLET, TABLET, CHEWABLE

Companies

Active Ingredient: CEFIXIME

SUPRAX Approval History

Loading approval history...

What SUPRAX Treats

6 indications

SUPRAX is approved for 6 conditions since its original approval in 1989. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Urinary Tract Infection
  • Otitis Media
  • Pharyngitis
  • Tonsillitis
  • Chronic Bronchitis
  • Gonorrhea
Source: FDA Label

Drugs Similar to SUPRAX

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CEFUROXIME AXETIL
CEFUROXIME AXETIL
4 shared
Aurobindo Pharma
Shared indications:
PharyngitisTonsillitisUrinary Tract Infection +1 more
AZITHROMYCIN
AZITHROMYCIN
2 shared
Aurobindo Pharma
Shared indications:
PharyngitisTonsillitis
CEFPODOXIME PROXETIL
CEFPODOXIME PROXETIL
2 shared
ANDA REPOSITORY
Shared indications:
PharyngitisTonsillitis
CEFUROXIME
CEFUROXIME
2 shared
Hikma
Shared indications:
Urinary Tract InfectionGonorrhea
CLARITHROMYCIN
CLARITHROMYCIN
2 shared
Teva
Shared indications:
PharyngitisTonsillitis
AMOXICILLIN PEDIATRIC
AMOXICILLIN
1 shared
Teva
Shared indications:
Urinary Tract Infection
AMPICILLIN SODIUM
AMPICILLIN SODIUM
1 shared
SAGENT PHARMS INC
Shared indications:
Urinary Tract Infection
ANCOBON
FLUCYTOSINE
1 shared
BAUSCH
Shared indications:
Urinary Tract Infection
ARFORMOTEROL TARTRATE
ARFORMOTEROL TARTRATE
1 shared
Cipla
Shared indications:
Chronic Bronchitis
ARIKAYCE KIT
AMIKACIN SULFATE
1 shared
INSMED INC
Shared indications:
Urinary Tract Infection
ATROVENT HFA
IPRATROPIUM BROMIDE
1 shared
Boehringer Ingelheim
Shared indications:
Chronic Bronchitis
AUGMENTIN '125'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AUGMENTIN '250'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AUGMENTIN '875'
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AUGMENTIN XR
AMOXICILLIN
1 shared
US ANTIBIOTICS
Shared indications:
Urinary Tract Infection
AZACTAM
AZTREONAM
1 shared
Bristol-Myers Squibb
Shared indications:
Urinary Tract Infection
AZTREONAM
AZTREONAM
1 shared
Pfizer
Shared indications:
Urinary Tract Infection
BACTRIM
SULFAMETHOXAZOLE
1 shared
Sun Pharma
Shared indications:
Urinary Tract Infection
BACTRIM DS
SULFAMETHOXAZOLE
1 shared
Sun Pharma
Shared indications:
Urinary Tract Infection
BICILLIN C-R 900/300
PENICILLIN G BENZATHINE
1 shared
KING PHARMS LLC
Shared indications:
Otitis Media
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

SUPRAX FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Cefixime for oral suspension is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections Otitis Media Pharyngitis and Tonsillitis Acute Exacerbations of Chronic Bronchitis Uncomplicated Gonorrhea (cervical/urethral) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime for oral suspension and other antibacterial drugs, cefixime for oral suspension should be used only to treat infections that are proven or strongly suspected t...

SUPRAX Patents & Exclusivity

Latest Patent: Dec 2028

Patents (1 active)

US9233112 Expires Dec 14, 2028
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.